Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 0 | 0 | 4,010 | 18,394 |
| Cost of Goods | N/A | N/A | N/A | 651 | 5,820 |
| Gross Profit | N/A | N/A | N/A | 3,359 | 12,574 |
| Operating Expenses | 55,685 | 42,471 | 37,510 | 38,500 | 38,476 |
| Operating Income | -55,685 | -42,471 | -37,510 | -34,490 | -25,082 |
| Interest Expense | 88 | 807 | 0 | 0 | 0 |
| Other Income | 10,468 | 4,715 | 13,197 | 902 | -376 |
| Pre-tax Income | -45,305 | -38,563 | -24,313 | -33,588 | -25,458 |
| Income Tax | 235 | -32 | 244 | -688 | -8,044 |
| Net Income Continuous | -45,540 | -38,531 | -24,557 | -32,900 | -17,414 |
| Net Income | $-45,540 | $-38,531 | $-24,557 | $-32,900 | $-17,414 |
| EPS Basic Total Ops | -1.49 | -1.26 | -0.81 | -1.08 | -0.58 |
| EPS Basic Continuous Ops | -1.49 | -1.26 | -0.81 | -1.08 | -0.58 |
| EPS Diluted Total Ops | -1.49 | -1.26 | -0.81 | -1.08 | -0.58 |
| EPS Diluted Continuous Ops | -1.49 | -1.26 | -0.81 | -1.08 | -0.58 |
| EPS Diluted Before Non-Recurring Items | -1.49 | -1.26 | -0.81 | -1.08 | -0.58 |
| EBITDA(a) | $-53,999 | $-40,726 | $-35,766 | $-31,876 | $-22,434 |